In the BioHarmony Drug Report Database
Clomipramine
Anafranil (clomipramine) is a small molecule pharmaceutical. Clomipramine was first approved as Anafranil on 1989-12-29. It is used to treat depressive disorder, obsessive-compulsive disorder, pain, panic disorder, and psychotic affective disorders in the USA. The pharmaceutical is active against sodium-dependent noradrenaline transporter and sodium-dependent serotonin transporter. In addition, it is known to target G protein-activated inward rectifier potassium channel 4, G protein-activated inward rectifier potassium channel 2, sodium-dependent dopamine transporter, and second secreted glycoprotein;small secreted glycoprotein;spike glycoprotein.
Trade Name
|
Anafranil |
|---|---|
Common Name
|
clomipramine |
ChEMBL ID
|
CHEMBL415 |
Indication
|
depressive disorder, obsessive-compulsive disorder, pain, panic disorder, psychotic affective disorders |
Drug Class
|
Antidepressants (imipramine type) |
Image (chem structure or protein)